Honey vesicle-like nanoparticles protect aged liver from non-alcoholic steatohepatitis

• Main Authors: Baolong Liu (Author), Phuong Linh Nguyen (Author), Han Yu (Author), Xingzhi Li (Author), Huiren Wang (Author), Tram Gia Bao Nguyen (Author), Prakash Kumar Sahoo (Author), Meghna Sur (Author), Jay Reddy (Author), Sarah Sillman (Author), Stephen D. Kachman (Author), Bara Altartouri (Author), Guoqing Lu (Author), Sathish Kumar Natarajan (Author), Mahesh Pattabiraman (Author), Jiujiu Yu (Author)
• Format: Book
• Published: Elsevier, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Non-alcoholic steatohepatitis (NASH), an advanced form of non-alcoholic fatty liver disease (NAFLD), has emerged as the leading cause of liver failure and related death. Currently, no medication is specifically approved to treat NAFLD or NASH. Here we report that oral administration of honey vesicle...